PolicyBrief
H.R. 6780
119th CongressDec 17th 2025
Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition Act
IN COMMITTEE

This bill establishes federal programs and research priorities to advance domestic capabilities in food biomanufacturing, workforce development, and innovation for diversifying edible protein sources.

Julia Brownley
D

Julia Brownley

Representative

CA-26

LEGISLATION

New Bill Pumps $100 Million Annually into Biomanufactured Protein Research and Factory Construction

If you’ve heard the term “bioeconomy” thrown around but aren’t sure what it means, this bill—the Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition Act—is a crash course. Essentially, it’s a massive federal push to diversify where our food, specifically protein, comes from. The bill aims to position the U.S. as a global leader in food biomanufacturing and bioprocessing, which means using technology to convert things like under-utilized plant waste (biomass) into edible proteins and fats at a large scale. Think of it as a significant investment in the future of food, starting in fiscal year 2026.

The Federal Mandate to Innovate

This isn't just about a few small grants; it’s a whole-of-government strategy. The USDA is tasked with recognizing at least three Centers of Excellence for Food and Agriculture Innovation, with one specifically required to be led by an 1890 Institution (a historically Black land-grant university). These centers get $15 million annually from 2026 through 2030 to focus on research and, crucially, workforce development (SEC. 3). This means if you’re a student or looking for a career change, these centers are where the new food science and biomanufacturing jobs will be trained. The bill also amends the existing Agriculture and Food Research Initiative (AFRI) to add “developing tools and production methods that increase the availability of edible protein sources” as a top research priority (SEC. 4). This directs existing research dollars toward this new field.

Building Factories and Training the Workforce

Perhaps the biggest chunk of money goes into directly funding the infrastructure needed to make these new proteins. The bill establishes a Food Biomanufacturing and Production Grant Program with $50 million authorized annually through 2030 (SEC. 6). The minimum grant size is $10 million, and the funds must be used for demonstration projects, constructing new commercial-scale facilities, or retrofitting existing U.S. facilities. To qualify for this money, the company must be headquartered, operate primarily in the U.S., and be at least 51% owned by U.S. citizens using U.S.-owned intellectual property. This is clearly designed to keep the technology and the manufacturing base here at home.

To staff these new factories, the bill also creates a Food Bioworkforce Development Grant Program with $25 million authorized annually (SEC. 7). This money can be used by governmental entities, tribes, and private organizations to train new and existing employees, establish training centers, and provide scholarships, including at community colleges. For the average worker, this means federal funding is flowing directly into training programs for high-tech manufacturing jobs, which often translates to higher wages and more specialized skills.

The Real-World Impact: Resilient Supply Chains

Why all the fuss over biomanufactured protein? The findings section of the bill makes it clear: this is about national security and economic resilience. By diversifying the U.S. protein supply, the country becomes less reliant on foreign commodities and less vulnerable to supply chain shocks—think of the meat shortages we saw during the early days of the pandemic. For consumers, this means more choices and potentially more stable prices in the long run. For farmers, the new focus on converting “under-utilized biomass” into high-value ingredients could create new markets for agricultural waste products that previously had little value (SEC. 5). The bill also mandates the USDA coordinate with agencies like the Department of Defense and the FDA to create a National Strategy on Alternative Proteins within one year, ensuring a cohesive, long-term federal plan (SEC. 8).

This bill explicitly states that nothing in it should be interpreted as endorsing or promoting the production of insects for human food or animal feed (SEC. 9). While the bill provides a clear path for companies to build large-scale biomanufacturing facilities, it gives the Secretary of Agriculture significant discretion in determining which facilities or projects are “qualified” for the large grants (SEC. 6). This is an area to watch, as the Secretary’s interpretation could significantly impact which companies receive the multi-million dollar awards.